Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cytokinetics Inc (NASDAQ:CYTK)

14.30
Delayed Data
As of Sep 22
 +0.10 / +0.70%
Today’s Change
8.69
Today|||52-Week Range
17.20
+17.70%
Year-to-Date

Today’s Trading

Previous close14.20
Today’s open14.15
Day’s range14.07 - 14.55
Volume430,672
Average volume (3 months)497,355
Market cap$767.4M
Dividend yield--
Data as of 3:59pm ET, 09/22/2017

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-652.38%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)+271.30%
P/E ratioNM
Price/Sales4.86
Price/Book6.16

Competitors

 Today’s
change
Today’s
% change
ITCIIntra-Cellular Thera...+0.04+0.21%
AKAOAchaogen Inc+0.10+0.64%
RETAReata Pharmaceutical...+0.13+0.41%
AKBAAkebia Therapeutics ...+0.05+0.29%
Data as of 4:00pm ET, 09/22/2017

Financials

Next reporting dateNovember 2, 2017
EPS forecast (this quarter)-$0.61
Annual revenue (last year)$106.4M
Annual profit (last year)$16.5M
Net profit margin15.46%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Robert I. Blum
Chief Financial Officer &
Senior Vice President
Ching Jaw
Corporate headquarters
South San Francisco, California

Forecasts